| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | TScan Therapeutics, Inc. | TCRX | Grant | Stock Option (Right to Buy) | 430k | $2.49 | $1.1M | | 06/13/2023 |
| 02/02/2023 | TScan Therapeutics, Inc. | TCRX | Grant | Stock Option (Right to Buy) | 35k | $1.81 | $63.4k | | 02/02/2023 |
| 07/25/2022 | TScan Therapeutics, Inc. | TCRX | Grant | Stock Option (Right to Buy) | 50k | $3.27 | $163.5k | | 07/25/2022 |
| 01/18/2022 | TScan Therapeutics, Inc. | TCRX | Grant | Stock Option (Right to Buy) | 85k | $4.85 | $412.2k | | 01/18/2022 |
| 09/23/2021 | TScan Therapeutics, Inc. | TCRX | Purchase | Voting Common Stock | 4.7k | $7.48 | $35.3k | | 09/23/2021 |
| 09/07/2021 | TScan Therapeutics, Inc. | TCRX | Grant | Stock Option (right to buy) | 150k | $8.99 | $1.3M | | 09/07/2021 |
| 02/10/2020 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 60k | $12.28 | $736.8k | | 02/10/2020 |
| 12/24/2019 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 7.9k | $16.00 | $126.4k | | 12/24/2019 |
| 12/24/2019 | Magenta Therapeutics, Inc. | MGTA | Exercise | Stock Option (Right to Buy) | 820 | $7.71 | $6.3k | | 12/23/2019 |
| 12/24/2019 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 7.9k | $16.00 | $126.4k | | 12/23/2019 |
| 12/23/2019 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 4.2k | $16.03 | $67k | | 12/23/2019 |
| 12/23/2019 | Magenta Therapeutics, Inc. | MGTA | Exercise | Stock Option (Right to Buy) | 9 | $7.71 | $69.4 | | 12/23/2019 |
| 12/23/2019 | Magenta Therapeutics, Inc. | MGTA | Exercise | Stock Option (Right to Buy) | 4.2k | $9.49 | $39.6k | | 12/23/2019 |
| 02/05/2019 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 80k | $7.13 | $570.4k | | 02/05/2019 |
| 06/25/2018 | Magenta Therapeutics, Inc. | MGTA | Conversion | Series C Preferred Stock | 12k | $0.00 | $0 | | 06/25/2018 |
| 06/25/2018 | Magenta Therapeutics, Inc. | MGTA | Conversion | Common Stock | 4.6k | $0.00 | $0 | | 06/25/2018 |